MAPT and early-onset autosomal dominant Alzheimer disease: Cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau, and quantification of cortical amyloid burden by positron emission tomography (PET) remain among the best‐established biomarkers of Alzheimer's disease (AD).